This nausea is most likely to occur during two key periods: When you first start treatment: Your body needs time to adjust to the medication
Manufacturer Savings Card Lilly savings card can reduce cost to $25/month for up to 13 fills Only works if Zepbound is covered by your insurance does NOT work for TFL exclusions or cash pay See our savings card guide 6
Amylin/Calcitonin Receptor Agonism (cagrilintide) Delays gastric emptying, reduces postprandial glucagon, and strongly promotes satiety Modulates appetite-regulating centers in the hindbrain, hypothalamus, and brain reward circuits, directly influencing food intake and choice May transiently activate the renin-angiotensin-aldosterone system with dose escalation, but without blood pressure or electrolyte derangements GLP-1 Receptor Agonism (semaglutide) Stimulates glucose-dependent insulin secretion and suppresses glucagon release to improve glycemic control Reduces appetite and ad libitum energy intake, with central effects on GLP-1R-expressing nuclei in hypothalamus and brainstem Delays gastric emptying and increases satiety, contributing to progressive bodyweight loss Pharmacokinetic Profile Route of Administration Subcutaneous Dosing Frequency Once weekly Route of Administration : Subcutaneous Injection Dosing Frequency: Once weekly Half -life: Cagrilintide: 7-8 days
Ready to start with Wegovy
Most rebound occurs within 3-6 months, with hunger hormones (especially ghrelin) rising significantly within 2-4 weeks of stopping
Dog, guinea pig, and rat CYP enzymes varied with the enzyme examined and were generally different from those in monkeys and humans
